mDR Limited Announces Significant Transactions in Quoted Securities

Singapore, 19 March 2026 – mDR Limited (“the Company” and together with its subsidiaries, “the Group”) has made a major announcement concerning its investment activities in quoted securities. The details, released in accordance with the Listing Manual of the Singapore Exchange Securities Trading Limited, could be of significant interest to shareholders and investors.

Key Highlights from the Announcement

• Acquisition of Quoted Securities:
  • The Group acquired quoted securities worth approximately S\$11,366,202 between 06 March 2026 and 17 March 2026.
  • This acquisition represents 7.7% of the Group’s latest audited net tangible assets (NTA).
• Sale of Quoted Securities:
  • The Group disposed of quoted securities (at historical cost) amounting to S\$5,614,508 during the same period.
  • This disposal equates to 3.8% of the Group’s latest audited consolidated net tangible assets.
• Impact on Investment Portfolio:
  • Before Acquisition:
  • Aggregate cost of quoted investments: S\$333,616,000
  • Percentage of NTA: 224.8%
  • Total market value: S\$238,271,000
  • Provision for diminution in value: Nil
  • After Acquisition:
  • Aggregate cost of quoted investments: S\$334,355,000
  • Percentage of NTA: 225.3%
  • Total market value: S\$239,974,000
  • Provision for diminution in value: Nil
• Audited consolidated net tangible assets (NTA) as at 31 December 2024: S\$148,431,000

Potential Implications for Shareholders

• The acquisition and disposal of quoted securities representing a combined over 11% of the Group’s NTA within a short span (11 days) is significant. This level of activity could impact the Group’s risk profile and future earnings, depending on the performance of the investments.
• The Group’s aggregate cost of quoted investments now stands at more than 225% of its latest audited NTA. This is an unusually high exposure, suggesting that the Group has a substantial portion of its resources tied up in quoted securities. Investors should closely monitor the valuation and market developments of these investments.
• No provision for diminution in value has been made, indicating that the Group currently believes the market value of its quoted investments is at least equal to their carrying value. However, any future adverse movements in the value of these investments could materially affect the Group’s financial position.

Price Sensitivity

Given the magnitude and relative size of the transactions, and the fact that the Group’s quoted investments far exceed its NTA, this announcement is price sensitive. Shareholders should take note of the elevated investment exposure, which could result in higher volatility in the Group’s financial results. Any significant changes in the market value of these investments may have an outsized impact on the Group’s balance sheet and share price.

Further Information

The announcement was approved by the Board and released by Company Secretary, Madan Mohan, on 19 March 2026.

Disclaimer: This article is for informational purposes only and does not constitute investment advice. Investors are advised to review the Group’s official filings and consult with their financial advisors before making any investment decisions. The author and publisher accept no responsibility for actions taken based on this report.

View MDR Limited Historical chart here